Bioheart, Inc.

Bioheart, Inc.

Sector: Electromedical And Electrotherapeutic Apparatus Region: FL, United States

: | OTC Markets: BHRT

Bioheart, Inc. is a biotechnology company focused on the discovery, development and, subject to regulatory approval, commercialization of autologous cell therapies for the treatment of chronic and acute heart damage. Its product are MyoCell, Myocell SDF-1, MyoCath and Lipicellan. The company was founded by Howard J. Leonhardt and Robert D. Lashinski on August 12, 1999 and is headquartered in Sunrise, FL.

News & Analysis

You may also be interested in: